793 related articles for article (PubMed ID: 18684186)
1. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
Nguyen GC; Sam J
Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
[TBL] [Abstract][Full Text] [Related]
2. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
Nguyen GC; Kaplan GG; Harris ML; Brant SR
Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in hospitalized inflammatory bowel disease patients: the magnitude of the problem is staggering.
Koutroubakis IE
Am J Gastroenterol; 2008 Sep; 103(9):2281-3. PubMed ID: 18684181
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients.
Nguyen GC; Patel H; Chong RY
Am J Gastroenterol; 2010 Feb; 105(2):371-7. PubMed ID: 19809406
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States.
Nguyen GC; Boudreau H; Harris ML; Maxwell CV
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):329-34. PubMed ID: 19027089
[TBL] [Abstract][Full Text] [Related]
6. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume.
Ananthakrishnan AN; McGinley EL; Binion DG
Am J Gastroenterol; 2008 Nov; 103(11):2789-98. PubMed ID: 18684184
[TBL] [Abstract][Full Text] [Related]
7. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.
Ananthakrishnan AN; McGinley EL; Binion DG
Gut; 2008 Feb; 57(2):205-10. PubMed ID: 17905821
[TBL] [Abstract][Full Text] [Related]
8. The utilization of parenteral nutrition during the in-patient management of inflammatory bowel disease in the United States: a national survey.
Nguyen GC; Laveist TA; Brant SR
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1499-507. PubMed ID: 17931346
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
10. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
Bernstein CN; Nabalamba A
Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
13. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis.
Longobardi T; Jacobs P; Bernstein CN
Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
[TBL] [Abstract][Full Text] [Related]
15. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension.
Sam J; Nguyen GC
Liver Int; 2009 Oct; 29(9):1396-402. PubMed ID: 19602136
[TBL] [Abstract][Full Text] [Related]
16. Health care resource utilization in inflammatory bowel disease.
Longobardi T; Bernstein CN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
[TBL] [Abstract][Full Text] [Related]
17. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
[TBL] [Abstract][Full Text] [Related]
19. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
[TBL] [Abstract][Full Text] [Related]
20. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
